NOVAVAX INC (NVAX) Free cash flow 2016–2021
NOVAVAX INC (NVAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$265.5MFY2021 · since FY2016: -$277.0M → $265.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $265.5M | +373.2% |
| FY2020 | -$97.2M | +29.8% |
| FY2019 | -$138.5M | +25.6% |
| FY2018 | -$186.2M | -25.2% |
| FY2017 | -$148.7M | +46.3% |
| FY2016 | -$277.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Net marginNVAX Gross profitNVAX Gross marginNVAX Operating incomeNVAX Operating marginNVAX Operating cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →